Literature DB >> 15471765

Effects of generic-only drug coverage in a Medicare HMO.

Jennifer Christian-Herman1, Matthew Emons, Dorothy George.   

Abstract

Rising pharmacy costs and demand for prescription drug coverage for broader populations of seniors have resulted in the implementation of generic-only pharmacy benefits in Medicare health maintenance organizations (HMOs). The impact on cost and quality of care is unknown. We examined data for members of a California Medicare HMO whose coverage changed to a generic-only benefit and found that the change was associated with reduced health plan pharmacy cost, increased out-of-pocket pharmacy costs for members, increased overall hospital admissions, changed drug-use patterns, and a negative impact on quality metrics for certain conditions. These findings have important implications for future research and health policy decisions.

Mesh:

Substances:

Year:  2004        PMID: 15471765     DOI: 10.1377/hlthaff.w4.455

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  9 in total

1.  How patient cost-sharing trends affect adherence and outcomes: a literature review.

Authors:  Michael T Eaddy; Christopher L Cook; Ken O'Day; Steven P Burch; C Ron Cantrell
Journal:  P T       Date:  2012-01

2.  Assessing the impact of drug use on hospital costs.

Authors:  Bruce C Stuart; Jalpa A Doshi; Joseph V Terza
Journal:  Health Serv Res       Date:  2008-09-08       Impact factor: 3.402

3.  Sensitivity of medication use to formulary controls in medicare beneficiaries: a review of the literature.

Authors:  Rahul Shenolikar; Amanda Schofield Bruno; Michael Eaddy; Christopher Cantrell
Journal:  Am Health Drug Benefits       Date:  2011-11

4.  Impact of drug policy on regional trends in ezetimibe use.

Authors:  Lingyun Lu; Harlan M Krumholz; Jack V Tu; Joseph S Ross; Dennis T Ko; Cynthia A Jackevicius
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-06-03

5.  Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.

Authors:  William H Shrank; Margaret Stedman; Susan L Ettner; Dee DeLapp; June Dirstine; M Alan Brookhart; Michael A Fischer; Jerry Avorn; Steven M Asch
Journal:  J Gen Intern Med       Date:  2007-07-24       Impact factor: 5.128

6.  Medication adherence and use of generic drug therapies.

Authors:  Becky A Briesacher; Susan E Andrade; Hassan Fouayzi; K Arnold Chan
Journal:  Am J Manag Care       Date:  2009-07       Impact factor: 2.229

7.  Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006.

Authors:  Pengxiang Li; J Sanford Schwartz; Jalpa A Doshi
Journal:  J Am Heart Assoc       Date:  2016-11-11       Impact factor: 5.501

8.  Is patients' insurance coverage associated with prescribing after hospitalization for severe, poorly controlled hypertension?

Authors:  Sydney Morss Dy; Michael J Klag; J Hunter Young
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-09       Impact factor: 3.738

Review 9.  Systematic review on quality control for drug management programs: is quality reported in the literature?

Authors:  Anke-Peggy Holtorf; Carrie McAdam-Marx; David Schaaf; Benjamin Eng; Gary Oderda
Journal:  BMC Health Serv Res       Date:  2009-02-25       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.